These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25472512)

  • 1. The medical isotope crisis: how we got here and where we are going.
    Ruth TJ
    J Nucl Med Technol; 2014 Dec; 42(4):245-8. PubMed ID: 25472512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Ways to Address Shortage Situations of
    Filzen LM; Ellingson LR; Paulsen AM; Hung JC
    J Nucl Med Technol; 2017 Mar; 45(1):1-5. PubMed ID: 28154015
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy of Sodium [99mTc] Pertechnetate from Low Specific Activity 99Mo/99mTc Autosolex Generator in Hospital Radiopharmacy Centre.
    Mitra A; Chattopadhyay S; Chandak A; Lad S; Barua L; De A; Kumar U; Chinagandham R; Upadhye T; Koundal K; Banerjee S; Rajan R
    Nucl Med Rev Cent East Eur; 2020; 23(1):1-14. PubMed ID: 32779168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technetium-99m production for use in nuclear medicine].
    Vucina J
    Med Pregl; 2000; 53(11-12):631-4. PubMed ID: 11320753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future of low specific activity molybdenum-99/technetium-99m generator.
    Mushtaq A
    Curr Radiopharm; 2012 Oct; 5(4):325-8. PubMed ID: 22642420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fission-Produced
    Youker AJ; Chemerisov SD; Tkac P; Kalensky M; Heltemes TA; Rotsch DA; Vandegrift GF; Krebs JF; Makarashvili V; Stepinski DC
    J Nucl Med; 2017 Mar; 58(3):514-517. PubMed ID: 27688474
    [No Abstract]   [Full Text] [Related]  

  • 8. 99Mo/(99m)Tc separation: an assessment of technology options.
    Dash A; Knapp FF; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclotron production of NCA 99mTc and 99Mo. An alternative non-reactor supply source of instant 99mTc and 99Mo----99mTc generators.
    Lagunas-Solar MC; Kiefer PM; Carvacho OF; Lagunas CA; Cha YP
    Int J Rad Appl Instrum A; 1991; 42(7):643-57. PubMed ID: 1663097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative production methods to face global molybdenum-99 supply shortage.
    Lyra M; Charalambatou P; Roussou E; Fytros S; Baka I
    Hell J Nucl Med; 2011; 14(1):49-55. PubMed ID: 21512666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New isotope production company gearing up for nuclear medicine industry.
    Kotz D
    J Nucl Med; 1998 Apr; 39(4):17N-18N, 27N. PubMed ID: 9544653
    [No Abstract]   [Full Text] [Related]  

  • 13. Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99m.
    Pillai MR; Knapp FF
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):385-99. PubMed ID: 23013668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.
    Boschi A; Martini P; Pasquali M; Uccelli L
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1402-1412. PubMed ID: 28443689
    [No Abstract]   [Full Text] [Related]  

  • 15. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
    Webster WD; Parks GT; Titov D; Beasley P
    Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of medical radionuclides in Russia: status and future--a review.
    Zhuikov BL
    Appl Radiat Isot; 2014 Feb; 84():48-56. PubMed ID: 24315977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
    Chakravarty R; Ram R; Dash A; Pillai MR
    Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators.
    Nakai K; Takahashi N; Hatazawa J; Shinohara A; Hayashi Y; Ikeda H; Kanai Y; Watabe T; Fukuda M; Hatanaka K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):413-21. PubMed ID: 25504230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionnaire survey of hospitals in Saitama Prefecture regarding the shortage of 99mTc-labeled radiopharmaceuticals and 99Mo/99mTc generators.
    Kosuda S; Tomita H; Hayashi K; Kita T; Koike K; Arai T
    Ann Nucl Med; 2010 May; 24(4):319-23. PubMed ID: 20204551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactors are indispensable for radioisotope production.
    Mushtaq A
    Ann Nucl Med; 2010 Dec; 24(10):759-60. PubMed ID: 20976574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.